Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2005
12/29/2005US20050287596 Novel ligands and libraries of ligands
12/29/2005US20050287595 obtaining a sample from a patient; conducting mass spectrometric analysis on the sample in a manner effective to maximize analysis of peptide fragments contained therein and comparing mass spectrum profiles of biopolymer marker and sample peptide
12/29/2005US20050287594 Activity-based probes having specificity to the active form of enzymes and receptors; screening for desired biological activities or target proteins
12/29/2005US20050287590 Multi-functional microarrays and methods
12/29/2005US20050287589 High resolution DNA detection methods and devices
12/29/2005US20050287588 Breast cancer specific gene 1
12/29/2005US20050287583 Methods and kits for isolating biological target materials using silica magnetic particles
12/29/2005US20050287580 Isolating biological modulators from biodiverse gene fragment libraries
12/29/2005US20050287579 Genes for male accessory gland proteins in Drosophila melanogaster
12/29/2005US20050287577 flow channel for delivering the sample, magnetic particles immobilized in the flow channel,capable of capturing the target substance, aggregating fine particles in a desired region in the flow channel, introducing a sample into the flow channel, allowing fine particles to react with the target
12/29/2005US20050287576 Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
12/29/2005US20050287571 determining the amount of defensin bound to sperm and comparing with a standard control, wherein a decrease in the amount from the standard control indicates a decrease in fertility in the male
12/29/2005US20050287570 Probe arrays for expression profiling of rat genes
12/29/2005US20050287569 For therapy and diagnosis of Escherichia coli infections
12/29/2005US20050287567 JM-27 as a marker of benign prostatic hyperplasia
12/29/2005US20050287565 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/29/2005US20050287560 Method for preparing substrates having immobilized molecules and substrates
12/29/2005US20050287557 Methods for identifying compounds for treating diabetes mellitus
12/29/2005US20050287554 Regions of papilloma virus E1 helicase involved in E1 oligomerization
12/29/2005US20050287552 Enclosed metallic nanoparticles for use as diagnostic and drug delivery tools
12/29/2005US20050287546 Novel proteases
12/29/2005US20050287543 Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer
12/29/2005US20050287540 Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences
12/29/2005US20050287537 Amino acid modification; improved thermostability, altered substrate specificity, ph optimum and cleavage pattern; economical and efficient
12/29/2005US20050287535 Biomarkers for wound healing
12/29/2005US20050287533 Target-specific compomers and methods of use
12/29/2005US20050287532 Methods for monitoring drug activities in vivo
12/29/2005US20050287530 TCL-1b gene and protein and related methods and compositions
12/29/2005US20050287529 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof
12/29/2005US20050287528 Methods for detecting ovarian cancer
12/29/2005US20050287527 Quantitative ranking of transient ligand binding to target biomolecules
12/29/2005US20050287525 bioassay for testing peptides that bind to domain peptides of human immunodeficiency virus type I (HIV-1); peptides used for treating viral diseases
12/29/2005US20050287524 Differential serological diagnosis of equine infectious anemia virus infected and vaccinated horses using recombinant S2 protein
12/29/2005US20050287522 Detection of protein translocation by beta-galactosidase reporter fragment complementation
12/29/2005US20050287521 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof
12/29/2005US20050287520 Screening method and device, and new drug screening method and device
12/29/2005US20050287519 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/29/2005US20050287517 Modulator of sweet or umami taste using ligand binding assay; detecting change in conformation
12/29/2005US20050287252 Method and apparatus for meat scanning
12/29/2005US20050287176 Dna sequences that encode antigens, cloning expression proteins serological diagnosis of canine leishmaniosis and proteins with Chemical intermediates
12/29/2005US20050287166 Malarial pre-erythrocytic stage polypeptide molecules
12/29/2005US20050287165 Meningococcal antigens
12/29/2005US20050287164 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
12/29/2005US20050287163 Mycoplasma polypeptides
12/29/2005US20050287160 Useful for treatment and prevention of prostate cancer, especially when associated with bone metastases; also a cytotoxic T lymphocyte that specifically recognizes complex of HLA-A24 antigen and the cancer antigen peptide
12/29/2005US20050287154 Autophilic antibodies and method of making and using same
12/29/2005US20050287150 Antibodies against Clostridium difficile toxins and uses thereof
12/29/2005US20050287147 Cancer-linked gene as target for chemotherapy
12/29/2005US20050287146 Method of inhibiting Candida-related infections using donor selected or donor stimulated immunoglobulin compositions
12/29/2005US20050287141 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
12/29/2005US20050287136 human cytotoxic T-lymphocyte antigen 4 (CTLA-4); heavy and light chain sequences spanning the complementarity determining regions (CDRs), specifically from within FR1 and/or CDR1 through CDR3 and/or within FR4; administering an antibody or antigen-binding portion to treat a tumor
12/29/2005US20050287121 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/29/2005US20050287098 Compositions and methods for controlling hair growth
12/29/2005US20050287072 Administering a conjugate of a biocompatible entity and a light-generating moiety; and measuring photon emission through an opaque tissue of said mammalian subject from the light-generating moiety; used for tracking the progression of infection
12/29/2005US20050287070 Ligand-specific opening of a gated-porin channel in the outer membrane of living bacteria
12/29/2005US20050287066 Anti-rat angiotensin I-converting enzyme (ACE, CD143) monoclonal antibodies and uses thereof
12/29/2005US20050287043 Gas-monitoring assembly comprising one or more gas sensors and one or more getters, and method of using same
12/29/2005US20050287042 Nanofibers with modified optical properties
12/29/2005US20050287038 Remote control scheduler and method for autonomous robotic device
12/29/2005US20050287035 Electrode strips for testing small volumes
12/29/2005US20050285608 Electrostatic capacity type liquid state detecting sensor
12/29/2005US20050284773 Method of preventing reuse in an analyte measuring system
12/29/2005US20050284764 Methods and apparatus for electrophoresis of prior-cast, hydratable separation media
12/29/2005US20050284760 Preliophic moleculator using electric fields and gradients for manipulating molecules
12/29/2005US20050284758 Novel electrode design for biosensor
12/29/2005US20050284757 Analyte measuring system which prevents the reuse of a test strip
12/29/2005US20050284212 System and method for rheological characterization of granular materials
12/29/2005US20050284208 Gas detecting apparatus, gas detecting method and fuel cell vehicle
12/29/2005DE29924834U1 Waste water sample incinerator for measurement of total organic carbon has ball swivel lock with long service life for sample admission
12/29/2005DE20221466U1 Measuring assembly comprises combination of dielectric sensor and temperature sensor to determine quality of frying oil
12/29/2005DE202004020741U1 Mobile apparatus for determining noble metal content of catalytic converters, especially for recycle purposes, comprises comminuting, weighing and sampling devices
12/29/2005DE19850564B4 Verfahren zur Branderkennung mit Gassensoren Methods of fire detection with gas sensors
12/29/2005DE10257716B4 Optischer Sensor zur Bestimmung von Farbstoffkonzentrationen in flüssigen Medien und Verfahren zu dessen Betrieb Optical sensor for the determination of dye concentrations in liquid media and method for its operation
12/29/2005DE10246811B4 Verfahren zur Erkennung und Eingrenzung des Risikos für Brustkrebs durch den Mikronukleustest an zweikernigen Zellen Methods for the detection and limit the risk of breast cancer by the micronucleus test in binuclear cells
12/29/2005DE10221885B4 Sensor-Einheit, Sensor-Anordnung und Verfahren zum Betreiben einer Sensor-Einheit Sensor unit, the sensor arrangement and method of operating a sensor-unit
12/29/2005DE102005016524A1 Verfahren und Vorrichtung zur Erkennung von Rotorblatteis Method and apparatus for detection of Rotorblatteis
12/29/2005DE102004028267A1 Sorptionsmittel für Nukleinsäuren, enthaltend säureaktiviertes Schichtsilicat Sorbents for nucleic acids containing acid-activated layer
12/29/2005DE102004027957A1 Investigation of interactions between biomolecules of differing types, attaches biomolecules to backlit biochip using chemical spacers, and includes measurements with total internal reflection
12/29/2005DE102004027429A1 Verfahren zur Anwendung von auf Markerwerten basierenden Dichtekarten bei der Diagnose von Patienten mit Krankheiten insbesondere von Tumoren A process for the application of density maps based marker values ​​in the diagnosis of patients with diseases, in particular of tumors
12/29/2005DE102004027422A1 Vorrichtung zur Aufnahme von Blut und Abtrennung von Blutbestandteilen An apparatus for receiving blood and separation of blood components
12/29/2005DE102004027364A1 Porous, locally-transparent, treated substrate used to detect biochemical binding reactions, includes compartments surrounded by walls with metallic modification
12/29/2005DE102004026903A1 Determination of lipoprotein classes in body fluids comprises analyzing NMR spectra of a plasma or serum sample and measuring under different measuring conditions; and determining the different effects of these measuring conditions
12/29/2005DE102004025744A1 Surface of a solid support, useful for multiple parallel analysis of nucleic acids by optical methods, having low non-specific binding of labeled components
12/29/2005DE102004024617A1 Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung Differentially expressed in tumors gene products and their use
12/29/2005CA2814904A1 Apparatus and method for pharmaceutical production
12/29/2005CA2612146A1 Treating cancer
12/29/2005CA2571614A1 Screening methods using c-abl, fyn and syk in combination with tau protein
12/29/2005CA2571517A1 Uses of gpr100 receptor in diabetes and obesity regulation
12/29/2005CA2570395A1 Antibodies binding to cd34+/cd36+ fetal but not to adult cells
12/29/2005CA2570383A1 Filter device, the method, kit and use thereof
12/29/2005CA2570296A1 Compositions and methods for diagnosis and treatment of orthopoxviruses
12/29/2005CA2570186A1 System and method for quality assurance of a biosensor test strip
12/29/2005CA2570034A1 Diagnosis and treatment of siglec-6 associated diseases
12/29/2005CA2569988A1 Phage microarray profiling of the humoral response to disease
12/29/2005CA2569807A1 Oligomeric peptides and their use for the treatment of hiv infections
12/29/2005CA2569473A1 Particles embedded in a porous substrate for removing target analyte from a sample
12/29/2005CA2569472A1 Electrochemical urea sensors and methods of making the same
12/29/2005CA2569311A1 Stable isotope labeled polypeptide standards for protein quantitation
12/29/2005CA2568601A1 Peptide-based compounds
12/29/2005CA2568548A1 Use of protein rs15a as a marker for colorectal cancer
1 ... 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 ... 3937